Laura W Dillon

发表

Utility of plasma cell-free DNA for de novo detection and quantification of clonal hematopoiesis

L. Ferrucci, S. Kajigaya, N. Young, 2021, Haematologica.

Baseline TP53 mutations in Adults with SCD developing Myeloid Malignancy following Hematopoietic Cell Transplantation.

C. Hourigan, Yuesheng Li, M. Hsieh, 2020, Blood.

Prediction of HLA genotypes from single-cell transcriptome data

P. Khatri, C. Hourigan, J. Goldman, 2022, bioRxiv.

Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry

K. Oetjen, K. Lindblad, M. Goswami, 2018, bioRxiv.

Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry

K. Oetjen, K. Lindblad, M. Goswami, 2018, bioRxiv.

DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant.

S. Zeger, G. Gui, C. Hourigan, 2023, JAMA.

Measurable residual disease in patients undergoing allogeneic transplant for acute myeloid leukemia.

C. Hourigan, Laura W Dillon, L. Dillon, 2023, Best practice & research. Clinical haematology.

Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease.

H. Deeg, D. Porter, G. Gui, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pre-MEASURE: FLT3-ITD and mutated NPM1 measurable residual disease before allogeneic transplant in adults with AML in first remission

S. Zeger, G. Gui, C. Hourigan, 2022, medRxiv.

Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia

S. Zeger, C. Hourigan, A. Corner, 2023, medRxiv.

Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome

H. Deeg, D. Porter, G. Gui, 2020, medRxiv.